AlphaStocks
4.8
Weak

Elanco Animal Health Inc (ELAN)

Health Care / Pharmaceuticals

S&P MidCap 400

$23.12

Below average on several measures. Research carefully.

Weak

Score based on 4 of 5 models — moderate confidence

#620out of 1127 in Health Care

Is Elanco Animal Health Inc a Good Investment in 2026?

Elanco Animal Health Inc (ELAN) scores 4.8 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates Elanco Animal Health Inc as Attractive (5/9). However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 93%). Elanco Animal Health Inc currently trades above its estimated fair value of $15, suggesting limited upside at current prices. Elanco Animal Health Inc ranks #620 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-2.6Market Cap11B

Estimated Fair Value

$15.0154% above

Trading above estimated fair value — the market may be pricing in future growth.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Attractive

Growth rate vs price (PEG)

Greenblatt

Caution

Bottom half (rank 93%)

Frequently Asked Questions

Is Elanco Animal Health Inc (ELAN) a good investment?
Based on AlphaStocks' composite analysis, Elanco Animal Health Inc (ELAN) scores 4.8 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trading above estimated fair value — the market may be pricing in future growth.
What is Elanco Animal Health Inc's Piotroski F-Score?
Elanco Animal Health Inc's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ELAN overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $15, ELAN appears overvalued. The stock currently trades 54% above its estimated fair value. Trading above estimated fair value — the market may be pricing in future growth.
How does ELAN compare to other Health Care stocks?
Elanco Animal Health Inc ranks #620 out of 1127 stocks in the Health Care sector, placing it in the top 55% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about ELAN?
AlphaStocks evaluates ELAN using five proven investment models. Piotroski: Attractive; Buffett: Caution; Graham: Neutral; Lynch: Attractive; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 4.8/10.

Similar Stocks

PARRFTIAZN

Compare ELAN with

ELAN vs PARRELAN vs FTIELAN vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer